Highlights
1 patentProfile claimed by owner
About
Genome-based Personalized Diagnostic Kits
Genefron develops and produces personal genomic diagnostic kits. The company uses gene expression signatures derived from bioinformatic developments to provide in-vitro companion diagnostics. Genefron has fully developed diagnostic kits (CE marked and Israeli OTC) for viral and autoimmune diseases and therapies including rheumatoid arthritis, multiple sclerosis, and cytomegalovirus.
Identity
| Name | Genefron |
|---|---|
| Slug | genefron |
| Type / kind | startup |
| Crunchbase ID | genefron |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL7sxIIJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Hartom Street 19, Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/64717842 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportDigital Medical Diagnostics
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesConsumersDemographics & FamilyWomen
Business models
B2B
Tags
viral-diseasesmedical-technologiesbioinformaticsdiagnosticsgeneticsbiomarkersgenomicspregnancymultiple-sclerosischronic-patientslaboratorieswomenpersonalized-medicine
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}